zation, the parity of M/SU benefits, and the effects of integrated treatment of clinical care (Feldman, 1999).
The Network for the Improvement of Addiction Treatment, described in Chapter 4, is a university–treatment provider consortium that involves smaller and less technologically rich organizations. This model also could be replicated as a community laboratory for the conduct of translational research on M/SU care.
The committee’s recommendations call for action on the part of clinicians, health care organizations, purchasers, health plans, educational institutions, federal and state legislators and executive agencies, and many others. These recommendations are organized according to the entities charged with their implementation in Tables 9-1 through 9-8. Note that because many of the recommendations are relevant to multiple parties, they appear in more than one table. Also identified are the aims and rules from the Quality Chasm report supported by each recommendation.